2m 2m 2m 2m 2m 2m 2m
MILESTONE PHARMA (MIST)
NASDAQ
$0.69+$0.02 (+3.44%)
Price as of Nov 11, 2026 7:45 PM EST- $82.4MMarket Cap
- -65.33%1-Year Change
- BiotechnologyIndustry
MILESTONE PHARMA (MIST)
$0.69+$0.02 (+3.44%)
MIST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.66 | ||
Change | -$0.08 (-10.27%) | ||
Open | $0.73 | ||
High | $0.76 | ||
Low | $0.66 | ||
Previous Close | $0.74 | ||
Volume | 1,675,108 | ||
30-Day Average Volume | 964,909 | ||
1-Week Change | -12.79% | ||
1-Month Change | -13.44% | ||
1-Year Change | -65.33% | ||
3-Year Change | -77.24% | ||
5-Year Change | -88.05% | ||
Fundamentals | |||
Shares Outstanding | 124.5M | ||
Total Assets | $181.6M | ||
Market Cap | $82.4M | ||
Enterprise Value | -$28.1M | ||
Period: QTR TTM FY | |||
Revenue | $559,000.00 | ||
Net Income | -$28.6M | ||
Free Cash Flow | -$22.7M | ||
EBIT | -$27.6M | ||
EBITDA | -$27.5M | ||
Net Working Capital | $158.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -50 | ||
P/B | 5 | ||
P/E | -3 | ||
PEG | 1 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue